PIOVAN S.P.A. financials
PIOVAN S.P.A.
Country: IT Reporting currency: EUR Latest annual report: 2024-12-31
LEI:
8156007367A2044B7685 Financial statements
(EUR, as reported — unscaled; 114 line items across 2 annual periods)
| Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Employee benefits expense | €139.6M | €130.6M |
| Raw materials & consumables used | €245.6M | €248.7M |
| Operating profit (EBIT) | €58.4M | €64.7M |
| Finance costs | €3.6M | €3.3M |
| Profit before tax | €64.3M | €64.9M |
| Income tax expense | €17.9M | €16.0M |
| Profit for the year | €46.3M | €48.9M |
| — attributable to owners | €44.5M | €49.4M |
| — attributable to NCI | €1.8M | -€490.0K |
| Total comprehensive income | €53.2M | €44.8M |
| Cash flow statement | ||
| Net cash from operating activities | €56.5M | €55.5M |
| Net cash from investing activities | -€3.9M | -€9.3M |
| Purchase of PP&E (capex) | €12.8M | €8.4M |
| Purchase of intangibles | €1.1M | €1.3M |
| Net cash from financing activities | -€62.8M | -€47.6M |
| Dividends paid | €14.3M | €10.2M |
| Net change in cash | -€10.2M | -€1.4M |
| Balance sheet | ||
| Total assets | €531.6M | €504.7M |
| Non-current assets | €243.1M | €211.8M |
| Property, plant & equipment | €64.3M | €50.9M |
| Right-of-use assets | €16.5M | €16.7M |
| Intangible assets & goodwill | €146.6M | €120.3M |
| Inventories | €88.4M | €85.3M |
| Trade & other receivables | €80.0M | €80.0M |
| Cash & equivalents | €82.7M | €92.8M |
| Total equity | €203.9M | €171.3M |
| — attributable to owners | €182.3M | €168.7M |
| Non-controlling interests | €21.7M | €2.6M |
| Non-current liabilities | €133.8M | €120.6M |
| Long-term borrowings | €62.4M | €79.6M |
| Short-term borrowings | €1.3M | €666.0K |
| Current portion of long-term borrowings | €32.5M | €36.6M |
| Deferred tax liabilities | €15.8M | €12.8M |
| Derived metrics | ||
| Free cash flow | €43.7M | €47.1M |
| Operating margin | 10.4% | 11.6% |
| Net margin | 8.2% | 8.7% |
| Return on equity | 22.7% | 28.5% |
| Cash conversion ratio | 1.22× | 1.13× |
| Capex coverage | 4.40× | 6.59× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | €761.0K | €1.0M |
| Adjustments For Decrease Increase In Other Assets | €0 | €0 |
| Adjustments For Decrease Increase In Other Current Assets | €268.0K | -€2.0M |
| Adjustments For Decrease Increase In Trade Account Receivable | €280.0K | €7.2M |
| Adjustments For Depreciation and Amortisation Expense and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €15.2M | €13.8M |
| Adjustments For Finance Costs | €2.5M | €3.2M |
| Adjustments For Income Tax Expense | €17.9M | €16.0M |
| Adjustments For Increase Decrease In Employee Benefit Liabilities | €40.0K | €164.0K |
| Adjustments For Increase Decrease In Other Current Liabilities | -€2.9M | €875.0K |
| Adjustments For Increase Decrease In Other Liabilities | €0 | €0 |
| Adjustments For Increase Decrease In Trade Account Payable | €1.6M | -€4.2M |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | €0 | €427.0K |
| Adjustments For Provisions | €3.6M | €2.8M |
| Adjustments For Undistributed Profits of Investments Accounted For Using Equity Method | -€7.0M | -€1.2M |
| Adjustments For Unrealised Foreign Exchange Losses Gains | -€329.0K | €1.6M |
| Basic Earnings Loss Per Share From Continuing Operations | €0.87 | €0.97 |
| Cash Flows From Used In Decrease Increase In Shortterm Deposits and Investments | €6.6M | €0 |
| Cash Flows From Used In Increase Decrease In Current Borrowings | €676.0K | -€6.3M |
| Cash Flows From Used In Operations Before Changes In Working Capital | €85.5M | €87.0M |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | -€3.5M | €0 |
| Comprehensive Income Attributable To Noncontrolling Interests | €1.8M | -€498.0K |
| Comprehensive Income Attributable To Owners of Parent | €51.4M | €45.3M |
| Current Advances | €37.2M | €37.4M |
| Current Assets Other Than Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | €288.5M | €292.9M |
| Current Contract Assets | €16.4M | €8.8M |
| Current Contract Liabilities | €3.1M | €4.7M |
| Current Financial Assets | €108.0K | €6.6M |
| Current Liabilities Other Than Liabilities Included In Disposal Groups Classified As Held For Sale | €193.9M | €212.8M |
| Current Tax Assets Current | €9.1M | €6.3M |
| Current Tax Liabilities Current | €12.0M | €11.4M |
| Deferred Tax Assets | €13.5M | €11.9M |
| Depreciation Amortisation and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €15.2M | €13.8M |
| Diluted Earnings Loss Per Share From Continuing Operations | €0.86 | €0.96 |
| Dividends Recognised As Distributions To Owners Per Share | €0.27 | — |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | €54.0K | €221.0K |
| Equity and Liabilities | €531.6M | €504.7M |
| Expense By Nature | €513.3M | €505.9M |
| Finance Income | €2.6M | €1.8M |
| Gains Losses On Exchange Differences On Translation Net of Tax | €6.8M | -€3.5M |
| Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss | €579.0K | -€1.2M |
| Income Taxes Paid Refund Classified As Operating Activities | -€18.5M | -€17.8M |
| Increase Decrease Through Acquisition of Subsidiary | €16.6M | €1.3M |
| Increase Decrease Through Other Changes Liabilities Arising From Financing Activities | €25.0M | €3.9M |
| Increase Decrease Through Sharebased Payment Transactions | €4.0M | €208.0K |
| Increase Decrease Through Treasury Share Transactions | -€787.0K | €346.0K |
| Interest Paid Classified As Financing Activities | €2.4M | €3.2M |
| Issued Capital | €6.0M | €6.0M |
| Liabilities | €327.7M | €333.4M |
| Noncurrent Provisions For Employee Benefits | €5.6M | €5.6M |
| Other Adjustments For Noncash Items | €6.4M | €1.9M |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | €112.0K | -€189.0K |
| Other Current Assets | €11.9M | €13.2M |
| Other Current Financial Liabilities | €4.2M | €23.2M |
| Other Current Liabilities | €28.5M | €27.1M |
| Other Longterm Provisions | €8.2M | €5.5M |
| Other Noncurrent Assets | €617.0K | €570.0K |
| Other Noncurrent Financial Liabilities | €13.9M | €14.5M |
| Other Noncurrent Liabilities | €898.0K | €2.5M |
| Other Operating Income Expense | -€5.5M | -€4.8M |
| Other Revenue | €9.9M | €11.4M |
| Proceeds From Noncurrent Borrowings | €15.9M | €10.0M |
| Proceeds From Sales of Intangible Assets Classified As Investing Activities | €0 | €99.0K |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | €0 | €350.0K |
| Profit Loss From Discontinued Operations | €83.0K | €1.3M |
| Repayments of Noncurrent Borrowings | €37.7M | €33.9M |
| Reserve of Exchange Differences On Translation | €6.7M | €14.0K |
| Retained Earnings Profit Loss For Reporting Period | €44.5M | €49.4M |
| Revenue and Operating Income | €571.8M | €570.5M |
| Revenue From Contracts With Customers | €561.8M | €559.1M |
| Services Expense | €107.4M | €108.1M |
| Share of Other Comprehensive Income of Associates and Joint Ventures Accounted For Using Equity Method That Will Be Reclassified To Profit Or Loss Net of Tax | €0 | -€422.0K |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | €7.0M | €1.2M |
| Statutory Reserve | €1.2M | €1.2M |
| Trade and Other Current Payables To Trade Suppliers | €75.1M | €71.7M |
| Treasury Shares | €3.0M | €2.5M |
Methodology
Every line item above is a fact tagged in PIOVAN S.P.A.'s annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.